sdsP8010 Cae
sdsP8010 Cae
sdsP8010 Cae
1. Identification
Product identifier
Product No P8010
Synonyms None
Supplier Address
New England BioLabs
240 County Road
Ipswich, MA 01938
USA
Telefax 978-921-1350
Page 1 / 8
P8010 - Factor Xa Protease Revision date 19-Dec-2023
2. Hazard(s) identification
Classification
Label elements
Hazard statements
Other information
No information available.
3. Composition/information on ingredients
Substance
Not applicable.
Mixture
4. First-aid measures
Description of first aid measures
Eye contact Rinse thoroughly with plenty of water for at least 15 minutes, lifting lower and upper eyelids.
Consult a physician.
5. Fire-fighting measures
Page 2 / 8
P8010 - Factor Xa Protease Revision date 19-Dec-2023
Suitable Extinguishing Media Use extinguishing measures that are appropriate to local circumstances and the
surrounding environment.
Large Fire CAUTION: Use of water spray when fighting fire may be inefficient.
Unsuitable extinguishing media Do not scatter spilled material with high pressure water streams.
Explosion data
Sensitivity to mechanical impact None.
Sensitivity to static discharge None.
Special protective equipment and Firefighters should wear self-contained breathing apparatus and full firefighting turnout gear.
precautions for fire-fighters Use personal protection equipment.
Advice on safe handling Handle in accordance with good industrial hygiene and safety practice.
Storage Conditions Keep containers tightly closed in a dry, cool and well-ventilated place.
Page 3 / 8
P8010 - Factor Xa Protease Revision date 19-Dec-2023
Respiratory protection No protective equipment is needed under normal use conditions. If exposure limits are
exceeded or irritation is experienced, ventilation and evacuation may be required.
General hygiene considerations Handle in accordance with good industrial hygiene and safety practice.
Other information
Explosive properties No information available
Oxidizing properties No information available
Softening point No information available
Molecular weight No information available
VOC content No information available
Liquid Density No information available
Bulk density No information available
Page 4 / 8
P8010 - Factor Xa Protease Revision date 19-Dec-2023
Inhalation Specific test data for the substance or mixture is not available.
Eye contact Specific test data for the substance or mixture is not available.
Skin contact Specific test data for the substance or mixture is not available.
Ingestion Specific test data for the substance or mixture is not available.
Acute toxicity .
The following values are calculated based on chapter 3.1 of the GHS document
ATEmix (oral) 20,233.70 mg/kg
ATEmix (dermal) 18,895.70 mg/kg
ATEmix (inhalation-gas) 99,999.00 ppm
ATEmix (inhalation-vapor) 99,999.00 mg/l
ATEmix (inhalation-dust/mist) 99,999.00 mg/l
Component Information
Delayed and immediate effects as well as chronic effects from short and long-term exposure
Skin corrosion/irritation No information available.
Page 5 / 8
P8010 - Factor Xa Protease Revision date 19-Dec-2023
Bioaccumulation
Component Information
Waste from residues/unused Dispose of in accordance with local regulations. Dispose of waste in accordance with
products environmental legislation.
Page 6 / 8
P8010 - Factor Xa Protease Revision date 19-Dec-2023
International Regulations
The Montreal Protocol on Substances that Deplete the Ozone Layer Not applicable
International Inventories
Legend:
TSCA - United States Toxic Substances Control Act Section 8(b) Inventory
DSL/NDSL - Canadian Domestic Substances List/Non-Domestic Substances List
EINECS/ELINCS - European Inventory of Existing Chemical Substances/European List of Notified Chemical Substances
ENCS - Japan Existing and New Chemical Substances
IECSC - China Inventory of Existing Chemical Substances
KECL - Korean Existing and Evaluated Chemical Substances
PICCS - Philippines Inventory of Chemicals and Chemical Substances
AICS - Australian Inventory of Chemical Substances
NZIoC - New Zealand Inventory of Chemicals
US Federal Regulations
SARA 313
Section 313 of Title III of the Superfund Amendments and Reauthorization Act of 1986 (SARA). This product does not contain any
chemicals which are subject to the reporting requirements of the Act and Title 40 of the Code of Federal Regulations, Part 372.
CERCLA
This material, as supplied, does not contain any substances regulated as hazardous substances under the Comprehensive
Environmental Response Compensation and Liability Act (CERCLA) (40 CFR 302) or the Superfund Amendments and
Reauthorization Act (SARA) (40 CFR 355). There may be specific reporting requirements at the local, regional, or state level
pertaining to releases of this material.
US State Regulations
California Proposition 65
Page 7 / 8
P8010 - Factor Xa Protease Revision date 19-Dec-2023
Key or legend to abbreviations and acronyms used in the safety data sheet
Key literature references and sources for data used to compile the SDS
Agency for Toxic Substances and Disease Registry (ATSDR)
U.S. Environmental Protection Agency ChemView Database
European Food Safety Authority (EFSA)
EPA (Environmental Protection Agency)
Acute Exposure Guideline Level(s) (AEGL(s))
U.S. Environmental Protection Agency Federal Insecticide, Fungicide, and Rodenticide Act
U.S. Environmental Protection Agency High Production Volume Chemicals
Food Research Journal
Hazardous Substance Database
International Uniform Chemical Information Database (IUCLID)
National Institute of Technology and Evaluation (NITE)
Australia National Industrial Chemicals Notification and Assessment Scheme (NICNAS)
NIOSH (National Institute for Occupational Safety and Health)
National Library of Medicine's ChemID Plus (NLM CIP)
National Library of Medicine’s PubMed database (NLM PUBMED)
National Toxicology Program (NTP)
New Zealand's Chemical Classification and Information Database (CCID)
Organization for Economic Co-operation and Development Environment, Health, and Safety Publications
Organization for Economic Co-operation and Development High Production Volume Chemicals Program
Organization for Economic Co-operation and Development Screening Information Data Set
World Health Organization
Page 8 / 8